insulin (Pharmedica)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinsulin (Pharmedica)
Drug Alias NameODF insulin
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmedica Laboratories (Proprietary) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmedica Laboratories (Proprietary) Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A